Role of angiotensin II and angiotensin-(1–7) in diabetes-induced oxidative DNA damage in the corpus cavernosum

Diabetes induces oxidative DNA damage in the corpus cavernosum. Angiotensin-(1–7), a counter-regulator of angiotensin II signaling, significantly attenuates DNA damage and structural changes in the corpus cavernosum.

Like Comment

Authors

Narayana Kilarkaje, Ph.D., Mariam H.M. Yousif, Ph.D., Ahmed Z. El-Hashim, Ph.D., Batoul Makki, M.Sc., Saghir Akhtar, Ph.D., Ibrahim F. Benter, Ph.D.

Volume 100, Issue 1, Pages 226-233, July 2013

Abstract

Objective:

To investigate diabetes mellitus (DM)-induced oxidative DNA damage, putative involvement of angiotensin (Ang) II, and possible modulatory effects of Ang-(1–7) in rat corpus cavernosum (CC).

Design:

In vivo study.

Setting:

Research laboratory.

Animal(s):

Adult male Wistar rats.

Intervention(s):

Streptozotocin-induced diabetic rats received either captopril, losartan (both 300 mg/L in drinking water), or Ang-(1–7) (576 μg/kg/d IP) for a 3-week period immediately before sacrifice at 6 weeks of DM.

Main Outcome Measure(s):

Histopathological changes in CC were examined in Masson’s trichrome-stained tissue sections. Oxidative stress was evaluated by measuring total oxidant status and antioxidant status. The DNA damage was estimated by measuring 8-hydroxy-2′-deoxyguanosine by immunohistochemistry and ELISA.

Result(s):

The CC smooth muscle degeneration was observed in association with an increase in total oxidant status and a decrease in total antioxidant status in rats with DM. Oxidative DNA damage was significantly increased in both cytoplasm and nuclei of CC in DM. Treatment with captopril, losartan, or Ang-(1–7) inhibited these changes in rats with DM.

Conclusion(s):

The data indicate that Ang II signaling is involved in DM-induced structural changes and oxidative DNA damage in the CC and that modulation of the signaling by captopril, losartan, and Ang-(1–7) restores the effects of DM. Thus, Ang-(1–7)/MAS1 axis may be a novel therapeutic target for erectile dysfunction in DM.

Read the full text at: http://www.fertstert.org/article/S0015-0282(13)00345-2/fulltext


Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.